[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.3,"TPM_sd":22.49,"TPM_min":0.93,"TPM_25th_percentile":5.43,"TPM_median":11.61,"TPM_75th_percentile":26.21,"TPM_max":180.54},{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.51,"TPM_sd":15.11,"TPM_min":0.93,"TPM_25th_percentile":6.78,"TPM_median":14.09,"TPM_75th_percentile":27.95,"TPM_max":68.29},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.49,"TPM_sd":17.33,"TPM_min":0,"TPM_25th_percentile":5.4,"TPM_median":10.1,"TPM_75th_percentile":17.74,"TPM_max":149.86},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.46,"TPM_sd":11.04,"TPM_min":0.21,"TPM_25th_percentile":7.3,"TPM_median":10.52,"TPM_75th_percentile":18.22,"TPM_max":64.48},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 53)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":40,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.74,"TPM_sd":18.46,"TPM_min":2.37,"TPM_25th_percentile":6.43,"TPM_median":7.99,"TPM_75th_percentile":9.31,"TPM_max":118.18},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 53)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.75,"TPM_sd":2.09,"TPM_min":4.06,"TPM_25th_percentile":5.53,"TPM_median":6.48,"TPM_75th_percentile":8.34,"TPM_max":11.37},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.57,"TPM_sd":18.31,"TPM_min":2.63,"TPM_25th_percentile":4.98,"TPM_median":6.58,"TPM_75th_percentile":9.61,"TPM_max":117.84},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.6,"TPM_sd":4.54,"TPM_min":3,"TPM_25th_percentile":4.73,"TPM_median":6.6,"TPM_75th_percentile":8.86,"TPM_max":17.5},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.42,"TPM_sd":1.05,"TPM_min":3.45,"TPM_25th_percentile":3.57,"TPM_median":4.25,"TPM_75th_percentile":4.82,"TPM_max":6.19},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.1,"TPM_sd":2.97,"TPM_min":6.13,"TPM_25th_percentile":6.39,"TPM_median":6.66,"TPM_75th_percentile":9.09,"TPM_max":11.51},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.99,"TPM_sd":29.19,"TPM_min":2.68,"TPM_25th_percentile":4.77,"TPM_median":5.95,"TPM_75th_percentile":10.02,"TPM_max":97.97},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":28.52,"TPM_sd":40.07,"TPM_min":1.91,"TPM_25th_percentile":2.1,"TPM_median":7.13,"TPM_75th_percentile":35.84,"TPM_max":95.63},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 18)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.22,"TPM_sd":18.48,"TPM_min":4.96,"TPM_25th_percentile":5.8,"TPM_median":10.75,"TPM_75th_percentile":36.86,"TPM_max":52.56},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 18)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":21.01,"TPM_sd":29.71,"TPM_min":4.1,"TPM_25th_percentile":6.03,"TPM_median":9.69,"TPM_75th_percentile":14.99,"TPM_max":80.99},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 22)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":17,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.72,"TPM_sd":4.76,"TPM_min":2.01,"TPM_25th_percentile":3.52,"TPM_median":4.77,"TPM_75th_percentile":6.14,"TPM_max":23.26},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 22)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.24,"TPM_sd":4.27,"TPM_min":3.23,"TPM_25th_percentile":4.98,"TPM_median":9.03,"TPM_75th_percentile":9.94,"TPM_max":14.03},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.32,"TPM_sd":2.07,"TPM_min":2.31,"TPM_25th_percentile":2.88,"TPM_median":4.03,"TPM_75th_percentile":5.46,"TPM_max":6.92},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.86,"TPM_sd":1.73,"TPM_min":5.52,"TPM_25th_percentile":5.97,"TPM_median":6.15,"TPM_75th_percentile":6.98,"TPM_max":10.2},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.01,"TPM_sd":18.18,"TPM_min":0.86,"TPM_25th_percentile":5.62,"TPM_median":8.88,"TPM_75th_percentile":22.92,"TPM_max":86.15},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":48,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.94,"TPM_sd":14.19,"TPM_min":1.69,"TPM_25th_percentile":4.96,"TPM_median":6.77,"TPM_75th_percentile":9.99,"TPM_max":79.59},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.4,"TPM_sd":4.6,"TPM_min":2.95,"TPM_25th_percentile":5.81,"TPM_median":8.88,"TPM_75th_percentile":11.33,"TPM_max":23},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.15,"TPM_sd":3.17,"TPM_min":3.64,"TPM_25th_percentile":7.74,"TPM_median":10.56,"TPM_75th_percentile":10.96,"TPM_max":12.71},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.01,"TPM_sd":2.02,"TPM_min":9,"TPM_25th_percentile":11.78,"TPM_median":12.9,"TPM_75th_percentile":13.13,"TPM_max":13.24},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.51,"TPM_sd":7.51,"TPM_min":6.05,"TPM_25th_percentile":10.44,"TPM_median":12,"TPM_75th_percentile":15.07,"TPM_max":23.96},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.08,"TPM_sd":6.7,"TPM_min":0.36,"TPM_25th_percentile":5.27,"TPM_median":6.92,"TPM_75th_percentile":8.71,"TPM_max":58.85},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.98,"TPM_sd":2.74,"TPM_min":3.5,"TPM_25th_percentile":5.42,"TPM_median":6.17,"TPM_75th_percentile":7.72,"TPM_max":16.51},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.34,"TPM_sd":4.07,"TPM_min":4.69,"TPM_25th_percentile":7.51,"TPM_median":9.57,"TPM_75th_percentile":12.68,"TPM_max":18.7},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.65,"TPM_sd":4.48,"TPM_min":2.78,"TPM_25th_percentile":5.68,"TPM_median":8.58,"TPM_75th_percentile":10.09,"TPM_max":11.6},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.66,"TPM_sd":4.71,"TPM_min":0.95,"TPM_25th_percentile":5.34,"TPM_median":8.25,"TPM_75th_percentile":10.91,"TPM_max":25.97},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.46,"TPM_sd":3.97,"TPM_min":2.14,"TPM_25th_percentile":5.57,"TPM_median":7.57,"TPM_75th_percentile":11.87,"TPM_max":14.42},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":19,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":19.83,"TPM_sd":25.79,"TPM_min":2.21,"TPM_25th_percentile":6.08,"TPM_median":9.21,"TPM_75th_percentile":13.88,"TPM_max":86.91},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.61,"TPM_sd":2.43,"TPM_min":3.5,"TPM_25th_percentile":4.58,"TPM_median":7.26,"TPM_75th_percentile":8.29,"TPM_max":9.34},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":95,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.54,"TPM_sd":17.43,"TPM_min":2.75,"TPM_25th_percentile":7.06,"TPM_median":14.65,"TPM_75th_percentile":30.46,"TPM_max":81.59},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":34,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.46,"TPM_sd":8.27,"TPM_min":2.2,"TPM_25th_percentile":5.31,"TPM_median":7.34,"TPM_75th_percentile":10.56,"TPM_max":49.95},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":29,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.48,"TPM_sd":5.66,"TPM_min":0.95,"TPM_25th_percentile":4.93,"TPM_median":7.3,"TPM_75th_percentile":10.23,"TPM_max":25.74},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.72,"TPM_sd":5.62,"TPM_min":1.75,"TPM_25th_percentile":4.44,"TPM_median":6.86,"TPM_75th_percentile":10.84,"TPM_max":19.55},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.02,"TPM_sd":2.34,"TPM_min":2.75,"TPM_25th_percentile":6.6,"TPM_median":7.47,"TPM_75th_percentile":8.55,"TPM_max":9.18},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.81,"TPM_sd":1.11,"TPM_min":4.54,"TPM_25th_percentile":5.07,"TPM_median":5.92,"TPM_75th_percentile":6.66,"TPM_max":6.87},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 400)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":329,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.14,"TPM_sd":7.13,"TPM_min":1.27,"TPM_25th_percentile":6.04,"TPM_median":7.82,"TPM_75th_percentile":10.37,"TPM_max":88.25},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 400)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":71,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.8,"TPM_sd":4.32,"TPM_min":2.24,"TPM_25th_percentile":5.4,"TPM_median":6.92,"TPM_75th_percentile":9.42,"TPM_max":33.58},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.8,"TPM_sd":2.97,"TPM_min":3.12,"TPM_25th_percentile":5.04,"TPM_median":6.44,"TPM_75th_percentile":8.13,"TPM_max":15.47},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.51,"TPM_sd":6.35,"TPM_min":2.83,"TPM_25th_percentile":5.74,"TPM_median":6.61,"TPM_75th_percentile":7.83,"TPM_max":24.92},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.06,"TPM_sd":1.63,"TPM_min":3.22,"TPM_25th_percentile":4.42,"TPM_median":5.62,"TPM_75th_percentile":5.97,"TPM_max":6.33},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.41,"TPM_sd":3.41,"TPM_min":3.82,"TPM_25th_percentile":5.82,"TPM_median":7.82,"TPM_75th_percentile":9.21,"TPM_max":10.6},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":206,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.69,"TPM_sd":27.94,"TPM_min":1.59,"TPM_25th_percentile":8.82,"TPM_median":12.08,"TPM_75th_percentile":17.57,"TPM_max":241.56},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.08,"TPM_sd":8.43,"TPM_min":2.36,"TPM_25th_percentile":7.74,"TPM_median":10.51,"TPM_75th_percentile":13.61,"TPM_max":38.87},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.61,"TPM_sd":5.48,"TPM_min":3.16,"TPM_25th_percentile":5.04,"TPM_median":6.17,"TPM_75th_percentile":8.61,"TPM_max":33.84},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":11,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.26,"TPM_sd":2.2,"TPM_min":0.3,"TPM_25th_percentile":4.06,"TPM_median":5.58,"TPM_75th_percentile":6.57,"TPM_max":8.03},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 317)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":26.73,"TPM_sd":16.83,"TPM_min":2.63,"TPM_25th_percentile":13.48,"TPM_median":22.95,"TPM_75th_percentile":37.82,"TPM_max":101.37},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 317)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.62,"TPM_sd":4.76,"TPM_min":3.34,"TPM_25th_percentile":8.02,"TPM_median":11.36,"TPM_75th_percentile":12.4,"TPM_max":19.43},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.92,"TPM_sd":5.32,"TPM_min":2.63,"TPM_25th_percentile":9.29,"TPM_median":12.46,"TPM_75th_percentile":16.23,"TPM_max":26.87},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.76,"TPM_sd":4.15,"TPM_min":8.02,"TPM_25th_percentile":10.54,"TPM_median":11.94,"TPM_75th_percentile":14.48,"TPM_max":19.43},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.35,"TPM_sd":2.95,"TPM_min":1.88,"TPM_25th_percentile":2.99,"TPM_median":4.83,"TPM_75th_percentile":6.52,"TPM_max":12.81},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.01,"TPM_sd":2.51,"TPM_min":1.44,"TPM_25th_percentile":3.59,"TPM_median":5.17,"TPM_75th_percentile":6.36,"TPM_max":8.49},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.65,"TPM_sd":6.61,"TPM_min":6.48,"TPM_25th_percentile":9.14,"TPM_median":12.76,"TPM_75th_percentile":15.88,"TPM_max":36.92},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.13,"TPM_sd":2.96,"TPM_min":4.79,"TPM_25th_percentile":7.36,"TPM_median":9.29,"TPM_75th_percentile":10.22,"TPM_max":13.56},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":37.43,"TPM_sd":43.6,"TPM_min":3.69,"TPM_25th_percentile":7.42,"TPM_median":12.5,"TPM_75th_percentile":78.61,"TPM_max":102.03},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.05,"TPM_sd":6.59,"TPM_min":6.7,"TPM_25th_percentile":8.37,"TPM_median":10.04,"TPM_75th_percentile":14.72,"TPM_max":19.41},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.58,"TPM_sd":2.1,"TPM_min":2.58,"TPM_25th_percentile":4.04,"TPM_median":6.13,"TPM_75th_percentile":6.89,"TPM_max":8.45},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.08,"TPM_sd":2.25,"TPM_min":1.93,"TPM_25th_percentile":2.31,"TPM_median":3.32,"TPM_75th_percentile":5.5,"TPM_max":7.84},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.4,"TPM_sd":2.52,"TPM_min":3.28,"TPM_25th_percentile":4.52,"TPM_median":5.44,"TPM_75th_percentile":8.75,"TPM_max":11.28},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.81,"TPM_sd":3.06,"TPM_min":2.17,"TPM_25th_percentile":4,"TPM_median":5.94,"TPM_75th_percentile":7.75,"TPM_max":9.17},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.96,"TPM_sd":6.22,"TPM_min":3,"TPM_25th_percentile":5.51,"TPM_median":9.03,"TPM_75th_percentile":13.71,"TPM_max":19.09},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.76,"TPM_sd":2.08,"TPM_min":0.83,"TPM_25th_percentile":1.65,"TPM_median":2.47,"TPM_75th_percentile":3.72,"TPM_max":4.97},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.31,"TPM_sd":5.3,"TPM_min":2.45,"TPM_25th_percentile":8.68,"TPM_median":11.61,"TPM_75th_percentile":15.03,"TPM_max":34.82},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.26,"TPM_sd":5.58,"TPM_min":8.42,"TPM_25th_percentile":10.69,"TPM_median":13.4,"TPM_75th_percentile":15.9,"TPM_max":22.89},{"x_label":"All tissue subgroups  (Dataset = GTEx, Specimen = GTEx Normal Adult Tissues, N = 17382)","specimen_descriptor_fill":"GTEx Normal Adult Tissues","box_sample_count":17382,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"GTEx","Disease":"","GTEx_tissue_subgroup":"Adipose - Subcutaneous,Muscle - Skeletal,Artery - Tibial,Artery - Coronary,Heart - Atrial Appendage,Adipose - Visceral (Omentum),Uterus,Vagina,Breast - Mammary Tissue,Skin - Not Sun Exposed (Suprapubic),Minor Salivary Gland,Brain - Cortex,Adrenal Gland,Thyroid,Lung,Spleen,Pancreas,Esophagus - Muscularis,Esophagus - Mucosa,Esophagus - Gastroesophageal Junction,Stomach,Colon - Sigmoid,Small Intestine - Terminal Ileum,Colon - Transverse,Prostate,Testis,Nerve - Tibial,Skin - Sun Exposed (Lower leg),Heart - Left Ventricle,Brain - Cerebellum,Cells - Cultured fibroblasts,Blood,Artery - Aorta,Cells - EBV-transformed lymphocytes,Pituitary,Brain - Frontal Cortex (BA9),Brain - Caudate (basal ganglia),Brain - Nucleus accumbens (basal ganglia),Brain - Putamen (basal ganglia),Brain - Hypothalamus,Brain - Spinal cord (cervical c-1),Brain - Hippocampus,Brain - Anterior cingulate cortex (BA24),Ovary,Liver,Brain - Substantia nigra,Kidney - Cortex,Brain - Amygdala,Cervix - Ectocervix,Fallopian Tube,Cervix - Endocervix,Bladder,Kidney - Medulla","EFO":"","MONDO":"","GTEx_tissue_subgroup_UBERON":"UBERON_0002190,UBERON_0011907,UBERON_0007610,UBERON_0001621,UBERON_0006631,UBERON_0010414,UBERON_0000995,UBERON_0000996,UBERON_0008367,UBERON_0036149,UBERON_0006330,UBERON_0001870,UBERON_0002369,UBERON_0002046,UBERON_0008952,UBERON_0002106,UBERON_0001150,UBERON_0004648,UBERON_0006920,UBERON_0004550,UBERON_0000945,UBERON_0001159,UBERON_0001211,UBERON_0001157,UBERON_0002367,UBERON_0000473,UBERON_0001323,UBERON_0004264,UBERON_0006566,UBERON_0002037,UBERON_0013756,UBERON_0001496,UBERON_0000007,UBERON_0009834,UBERON_0001873,UBERON_0001882,UBERON_0001874,UBERON_0001898,UBERON_0006469,UBERON_0001954,UBERON_0009835,UBERON_0000992,UBERON_0001114,UBERON_0002038,UBERON_0001225,UBERON_0001876,UBERON_0012249,UBERON_0003889,UBERON_0000458,UBERON_0001255,UBERON_0001293","TPM_mean":11.35,"TPM_sd":6.03,"TPM_min":0.36,"TPM_25th_percentile":6.5,"TPM_median":11.01,"TPM_75th_percentile":15.19,"TPM_max":59.09}]